focusIR May 2024 Investor Webinar: Blue Whale, Kavango, Taseko Mines & CQS Natural Resources. Catch up with the webinar here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMaven Grwth 3 Regulatory News (MIG3)

Share Price Information for Maven Grwth 3 (MIG3)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 48.00
Bid: 47.00
Ask: 49.00
Change: 0.00 (0.00%)
Spread: 2.00 (4.255%)
Open: 48.00
High: 48.00
Low: 48.00
Prev. Close: 48.00
MIG3 Live PriceLast checked at -
Maven Income and Growth VCT 3 is an Investment Trust

To achieve long-term capital appreciation and generate income for Shareholders by investing in a diversified portfolio of securities in smaller, unquoted UK companies and AIM/NEX quoted companies.

Find out More

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Statement re NAV and Final Dividend

4 Feb 2022 09:45

RNS Number : 7485A
Maven Income and Growth VCT 3 PLC
04 February 2022
 

Maven Income and Growth VCT 3 PLC

 

Net Asset Value and Proposed Final Dividend

 

The Directors of Maven Income and Growth VCT 3 PLC ("the Company") confirm that the unaudited net asset value of the Company as at 30 November 2021 was 62.55p per Ordinary Share.

 

The Directors propose that a final dividend of 1.50p per Ordinary Share, in respect of the year ended 30 November 2021, be paid on 26 April 2022 to Shareholders on the register at close of business on 25 March 2022.

The Company has in place a Dividend Investment Scheme (DIS) through which Shareholders may elect to have their dividend payments used to apply for new Ordinary Shares issued by the Company under the standing authority requested from Shareholders at Annual General Meetings. Shares issued under the DIS should qualify for VCT tax reliefs applicable for the tax year in which they are allotted. Terms & conditions of the scheme, together with a mandate form, are available from the Company's website at: www.mavencp.com/migvct3.

Shareholders who have not previously applied to participate in the DIS and who wish to do so in respect of the dividend payable on 26 April 2022, should ensure that a mandate form is received by the Registrar, The City Partnership (UK) Limited, prior to the dividend election date of 8 April 2022.

 

Further to the information disclosed above, the Directors confirm that they are satisfied that all inside information (as defined by Article 7 of the Market Abuse Regulation (596/2014/EU)) that the Directors and the Company may have in their possession relating to the Company during the 30 day closed period leading up to the announcement of its annual results for the year ended 30 November 2021 has been or will be notified to a regulatory information service.

 

Issued on behalf of the Board

Maven Capital Partners UK LLP

Secretary

4 February 2022

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
STRFIFVAFAISIIF
Date   Source Headline
23rd Aug 20194:23 pmRNSStatement re Intended Joint Offer for Subscription
26th Jul 201911:25 amRNSHalf-year Report
10th Jul 20195:03 pmRNSTransaction in Own Shares
2nd Jul 20194:20 pmRNSUnaudited Net Asset Value and Interim Dividend
28th May 20193:13 pmRNSTransaction in Own Shares
11th Apr 201910:53 amRNSNet Asset Value(s)
10th Apr 201912:49 pmRNSResult of AGM
1st Mar 20193:01 pmRNSAnnual Financial Report
7th Feb 20194:34 pmRNSTransaction in Own Shares
17th Jan 20193:06 pmRNSNet Asset Value(s)
27th Nov 20182:42 pmRNSTransaction in Own Shares
21st Nov 20184:03 pmRNSNet Asset Value(s)
20th Jul 20184:04 pmRNSHalf-year Report
17th Jul 20184:09 pmRNSTransaction in Own Shares
3rd Jul 20184:30 pmRNSNet Asset Value(s)
22nd Jun 20184:30 pmRNSIssue of Equity
15th Jun 20184:49 pmRNSStatement re DIS
17th May 20184:30 pmRNSDividend Declaration
26th Apr 20189:35 amRNSDirector/PDMR Shareholding
24th Apr 20184:51 pmRNSIssue of Equity
16th Apr 20185:12 pmRNSNet Asset Value(s)
13th Apr 201812:47 pmRNSIssue of Equity
13th Apr 201811:59 amRNSPublication of Suppl.Prospcts
11th Apr 20181:12 pmRNSResult of AGM
6th Apr 20184:38 pmRNSStatement re Dividend Investment Scheme
6th Apr 20189:21 amRNSDirector/PDMR Shareholding
5th Apr 20186:22 pmRNSIssue of Equity
27th Mar 20185:44 pmRNSPublication of Suppl.Prospcts
9th Mar 20184:16 pmRNSAnnual Financial Report
8th Mar 20183:30 pmRNSDividend Declaration
2nd Mar 201812:34 pmRNSStatement re Offer for Subscription
13th Feb 20183:34 pmRNSTransaction in Own Shares
6th Feb 20185:14 pmRNSDirector/PDMR Shareholding
6th Feb 20185:13 pmRNSDirector/PDMR Shareholding
6th Feb 20185:12 pmRNSDirector/PDMR Shareholding
6th Feb 20185:06 pmRNSIssue of Equity
24th Jan 20184:41 pmRNSPublication of Suppl.Prospcts
19th Jan 20183:33 pmRNSNet Asset Value(s)
30th Nov 20174:31 pmRNSIssue of Equity
22nd Nov 20175:06 pmRNSTransaction in Own Shares
21st Nov 20173:45 pmRNSIssue of Equity
17th Nov 20175:05 pmRNSStatement re NAV and Dividend Investment Scheme
8th Nov 201710:11 amRNSResult of General Meeting
27th Oct 20173:26 pmRNSNet Asset Value(s)
25th Oct 20172:57 pmRNSDividend Declaration
22nd Sep 20176:25 pmRNSStatement re Offer for Subscription
22nd Sep 20176:25 pmRNSStatement re Offer for Subscription
15th Sep 20174:45 pmRNSIssue of Equity
15th Sep 201710:05 amRNSStatement re NAV and Dividend Investment Scheme
6th Sep 201711:37 amRNSForm 8.3 - Byotrol Plc

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.